Related Experiment Video

Updated: Jul 2, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Midkine mRNA is overexpressed in pancreatic cancer

Seiji Ohhashi1, Kenoki Ohuchida, Kazuhiro Mizumoto

  • 1Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, 812-8582, Japan.

Digestive Diseases and Sciences
|August 21, 2008
PubMed
Abstract

Insights

Quantitative analysis of Midkine (MK) mRNA shows higher expression in pancreatic cancer tissues. This suggests MK mRNA is a promising biomarker for diagnosing pancreatic cancer and predicting its prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Midkine (MK) is a potential molecular marker for pancreatic cancer diagnosis.
  • Quantitative analysis of MK mRNA is being explored as a diagnostic tool.

Purpose of the Study:

  • To investigate the feasibility of quantitative analysis of Midkine (MK) mRNA using quantitative real-time RT-PCR (qRT-PCR).
  • To evaluate MK mRNA as a promising tool for pancreatic cancer diagnosis.

Main Methods:

  • Quantitative real-time RT-PCR (qRT-PCR) was used for MK mRNA analysis.
  • MK mRNA expression levels were compared between pancreatic cancer tissues, intraductal pancreatic mucinous neoplasm (IPMN), and non-neoplastic pancreatic tissues.

Main Results:

  • Pancreatic cancer tissues exhibited significantly higher MK mRNA levels compared to IPMN and non-neoplastic tissues (P < 0.05).
  • No significant difference in MK mRNA expression was found between IPMN and non-neoplastic tissues.
  • Higher MK mRNA levels were observed in poorly differentiated carcinomas versus well-differentiated carcinomas, though not statistically significant.

Conclusions:

  • Quantitative MK mRNA analysis offers an objective and sensitive method for pancreatic cancer diagnosis.
  • MK mRNA may serve as a promising biomarker for pancreatic cancer diagnosis and prognosis prediction.

More Related Videos

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...